Efficiency of Different Supplements in Alleviating Symptoms of ADHD with or Without the Use of Stimulants: A Systematic Review.
Study Design
- 研究类型
- Systematic Review
- 研究人群
- ADHD patients (systematic review of supplements)
- 干预措施
- Efficiency of Different Supplements in Alleviating Symptoms of ADHD with or Without the Use of Stimulants: A Systematic Review. None
- 对照组
- Placebo or methylphenidate
- 主要结局
- ADHD symptom severity (inattention, hyperactivity)
- 效应方向
- Mixed
- 偏倚风险
- Moderate
Abstract
OBJECTIVE: This review aims to assess the efficacy and safety of different supplements, such as L-theanine, caffeine, Ginkgo biloba L., and Bacopa monnieri for improving ADHD symptoms, to determine the most effective supplement and provide insight for medical practice. METHODS: International databases (PubMed/MEDLINE and Scopus) were searched for English-language RCTs, open-label studies, and cross-sectional studies. RESULTS: Studies on L-theanine, caffeine, Ginkgo biloba L., and Bacopa monnieri have shown various effects on ADHD symptoms. L-theanine improved sleep efficiency but not other sleep parameters. Caffeine showed no significant benefits, although its combination with L-theanine may enhance attention. Bacopa monnieri consistently improved inattention, hyperactivity, and memory, whereas Ginkgo biloba L. reduced ADHD symptoms, particularly inattention, but was less effective than methylphenidate. CONCLUSIONS: The evidence revealed the potential use of supplements as complementary ADHD treatments under clinical guidance. The limited effect of supplements cannot replace the well-documented efficacy of stimulants for ADHD treatment. Additional studies are needed to ascertain the most effective dosages and the safety of these supplements as adjunctive treatments for ADHD.
简要概述
The evidence revealed the potential use of supplements as complementary ADHD treatments under clinical guidance, but the limited effect of supplements cannot replace the well-documented efficacy of stimulants for ADHD treatment.
Full Text
Used In Evidence Reviews
Similar Papers
CNS drugs · 2013
Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence.
Recent patents on endocrine, metabolic & immune drug discovery · 2011
Exploring the Role of “Brahmi” (Bacopa monnieri and Centella asiatica) in Brain Function and Therapy.
Alternative medicine review : a journal of clinical therapeutic · 1999
A review of nutrients and botanicals in the integrative management of cognitive dysfunction.
Drug target insights · 2019
Bacopa monnieri, a Neuroprotective Lead in Alzheimer Disease: A Review on Its Properties, Mechanisms of Action, and Preclinical and Clinical Studies.
Journal of ethnopharmacology · 2017
The Ayurvedic plant Bacopa monnieri inhibits inflammatory pathways in the brain.
Neurochemical research · 2012